All poster presentations will take place on Monday, June 12, 2023, from 12:15 to 1:30 p.m. EDT, or Tuesday, June 13, 2023, from 12:15 to 1:30 p.m. EDT at the Baltimore Convention Center, Exhibit Hall E, Level 100.
Abstract 4-M (Monday)
Avoiding Clinical Inertia: Comparing Time to Intensification of Glucagon-like
peptide-1 (GLP-1) Receptor Agonists in Patients with Type 2 Diabetes Mellitus Among Clinical Pharmacists versus Providers
Clinical pharmacists have a significant impact on medication optimization and reduction of HbA1c when included in collaborative patient care in the outpatient setting. A retrospective chart review was conducted to examine the impact of a clinical pharmacist on the treatment intensification of GLP-1 receptor agonists in patients with type 2 diabetes versus the typical standard of care without pharmacist involvement. Researchers reviewed the charts of 28 patients with type 2 diabetes who were prescribed semaglutide, liraglutide or dulaglutide and who had an HbA1c over 7%. The study found 85% of patients who received care from clinical pharmacists had their GLP-1 agonist titrated to the first effective dose in the recommended timeframe, compared to just 12.5% of patients who received standard of care. Patients treated by pharmacists also had a significantly larger reduction in HbA1c and faster time to treatment intensification beyond the first effect dose.
Abstract 25-T (Tuesday)
Price Transparency at the Point of Prescribing with Real-Time Prescription Benefits
Real-time prescription benefits (RTPB) is a tool that provides prescribers with patient-, medication-, and pharmacy-specific information on how much a medication is estimated to cost, if a prior authorization is needed, and if there are any lower-cost alternatives. The program displays an alert to physicians prescribing medication that alerts the prescriber to prior authorization requirements, price estimates, and alternative medication options. Researchers analyzed prescribing and RTPB data from March 2022 to March 2023 at Vanderbilt University Medical Center to determine the proportion of patients who picked up their medications, whether the system triggered an alert and whether an alternative was accepted. The results showed that about 5% of prescriptions generated alerts, with 77% alerting to a lower-cost alternative. When prescribers were alerted to and chose a lower cost alternative to prescriptions they were writing, patients were 15% more likely to pick up the prescription.
Abstract 38-T (Tuesday)
